Sandoz Group Ltd ( (CH:SDZ) ) has provided an update.
Sandoz has announced a new USD 2 billion multi-currency revolving credit facility to enhance its financial stability, replacing a previous USD 1.25 billion facility. The company has also issued CHF 400 million and EUR 500 million bonds, using the proceeds to repay USD 750 million in term loans, extending debt maturities to 2035, and reducing interest expenses. These financial maneuvers are expected to lower Sandoz’s annual interest rate on gross debt to below 4%, strengthening its balance sheet and providing significant financial flexibility.
More about Sandoz Group Ltd
Sandoz is a global leader in generic and biosimilar medicines, committed to pioneering access for patients. With a workforce of over 20,000 people from 100 nationalities, Sandoz provides approximately 900 million patient treatments, offering a portfolio of around 1,300 products that address a wide range of diseases. Headquartered in Basel, Switzerland, the company has a rich history of medical breakthroughs and recorded net sales of USD 10.4 billion in 2024.
YTD Price Performance: 4.22%
Average Trading Volume: 4,052
Technical Sentiment Signal: Sell
Current Market Cap: $18.96B
Find detailed analytics on SDZ stock on TipRanks’ Stock Analysis page.